Authors:
Haddad, E
Paczesny, S
Leblond, V
Seigneurin, JM
Stern, M
Achkar, A
Bauwens, M
Delwail, V
Debray, D
Duvoux, C
Hubert, P
de Ligny, BH
Wijdenes, J
Durandy, A
Fischer, A
Citation: E. Haddad et al., Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trial, BLOOD, 97(6), 2001, pp. 1590-1597
Authors:
Colombat, P
Salles, G
Brousse, N
Eftekhari, P
Soubeyran, P
Delwail, V
Deconinck, E
Haioun, C
Foussard, C
Sebban, C
Stamatoullas, A
Milpied, N
Boue, F
Taillan, B
Lederlin, P
Najman, A
Thieblemont, C
Montestruc, F
Mathieu-Boue, A
Benzohra, A
Solal-Celigny, P
Citation: P. Colombat et al., Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy forpatients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation, BLOOD, 97(1), 2001, pp. 101-106
Authors:
Deconinck, E
Lamy, T
Foussard, C
Gaillard, F
Delwail, V
Colombat, P
Casassus, P
Lemevel, A
Brion, A
Milpied, N
Citation: E. Deconinck et al., Autologous stem cell transplantation for anaplastic large-cell lymphomas: results of a prospective trial, BR J HAEM, 109(4), 2000, pp. 736-742
Authors:
Lacotte, L
Thierry, A
Delwail, V
Dreyfus, B
Guilhot, F
Citation: L. Lacotte et al., Thrombotic thrombocytopenic purpura during interferon alpha treatment for chronic myelogenous leukemia, ACT HAEMAT, 102(3), 1999, pp. 160-162